Converting Human Cells to Cancerous Cells

For this article, Leslie Pray interviewed William C. Hahn, postdoctoral fellow at the Whitehead Institute for Biomedical Research in Cambridge, Mass., and an oncologist at the Dana-Farber Cancer Institute in Boston. Data from the Web of Science (ISI, Philadelphia) show that Hot Papers are cited 50 to 100 times more often than the average paper of the same type and age. W.C. Hahn, C.M. Counter, A.S. Lundberg, R.L. Beijersbergen, M.W. Brooks, R.A. Weinberg, "Creation of human tumour cells with de

Written byLeslie Pray
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The genes were hTERT, a telomerase expression regulator, and a combination of two oncogenes: the simian virus 40 large-T oncoprotein and an oncogenic allele of H-ras. By disrupting the intracellular pathways regulated by these genes, Hahn and his colleagues directly converted normal human epithelial and fibroblast cells into cancer cells. The study shows how "using these sets of genes, you can turn a normal human cell into a cancer cell in one step," Hahn says.

Because hTERT plays such a key role, it follows that telomere maintenance is also critical in forming tumors by allowing pre-cancerous cells to continue replicating longer than normal, according to Hahn. In normal human cells, hTERT is not usually found and the telomeres progressively shorten with each round of cell division, until they reach the point where they stop replicating. In contrast, telomerase is turned on in most human tumors. In fact, the difference in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies